Warnaar, Kathleen – Trademark Portfolio
Entity Type: 01
Warnaar, Kathleen holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HOMELIFEIQ. The owner is based in Raleigh, NC.
6212 Carlyle Dr.
Raleigh, NC 27614
Showing of trademarks Trademarks
Trademark Classifications
Warnaar, Kathleen's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Warnaar, Kathleen have?
Warnaar, Kathleen has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Warnaar, Kathleen file in?
Warnaar, Kathleen files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Warnaar, Kathleen's most well-known trademarks?
Warnaar, Kathleen's registered trademark portfolio includes well-known marks such as HOMELIFEIQ. These are among 1 currently registered trademark in the portfolio.
What is Warnaar, Kathleen's trademark registration success rate?
Warnaar, Kathleen has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.